Footnotes

Chapter 1 - Introduction

[1]        House of Representatives Votes and Proceedings, No. 117—27 May 2015, p. 1317.

[2]        Journals of the Senate, No. 96—16 June 2015, pp. 2661–2.

[3]        Medical Research Future Fund Bill 2015, p. 1.

[4]        The Hon. Joe Hockey MP, Treasurer, Second Reading Speech, House of Representatives Proof Hansard, 27 May 2015, pp 4701–4703.

[5]        Australian Government, Budget Paper No. 2 2014-15, p. 115, http://budget.gov.au/2014-15/content/bp2/download/BP2_consolidated.pdf (accessed 20 July 2015). 

[6]        Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 4.

[7]        Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 4.

[8]        Medical Research Future Fund Bill 2015, clause 12(1), p. 13.

[9]        Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 4.

[10]      Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 4.

[11]      Section 42 (disallowance) of the Legislative Instruments Act 2003 does not apply to the above determinations.

[12]      Medical Research Future Fund Bill 2015, clause 18 and 19, pp 18–20.

[13]      Medical Research Future Fund Bill 2015, part 2 division 4 subdivision D, pp 22–23.

[14]      Medical Research Future Fund Bill, part 2A division 2, p. 28.

[15]      Medical Research Future Fund Bill, clause 32D, pp. 29.

[16]      Medical Research Future Fund Bill, clause 32E, p. 30.

[17]      Section 42 (disallowance) of the Legislative Instruments Act 2003 does not apply to the above determinations, nor does subsection 33(3) of the Acts Interpretation Act 1901.

[18]      Medical Research Future Fund Bill, clause 32F and 32G, p. 32.

[19]      Medical Research Future Fund Bill, clause 32G clause 2, p. 32.

[20]      Medical Research Future Fund Bill, clause 32G, clause 4, p. 32.

[21]      Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 5.

[22]      Medical Research Future Fund Bill 2015, clause 37, pp 38–39.

[23]      Medical Research Future Fund Bill 2015, clause 39, pp 39–40.

[24]      Medical Research Future Fund Bill 2015, clause 42(1), p. 42.

[25]      Section 42 (disallowance) of the Legislative Instruments Act 2003 does not apply to this direction.

[26]      Medical Research Future Fund Bill 2015, clause 42(2), p. 42.

[27]      Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 5.

[28]      Medical Research Future Fund Bill 2015, clause 55(1) and 56, p. 50.

[29]      Medical Research Future Fund Bill 2015, clause 57A and 58, p.50–51.

[30]      Medical Research Future Fund Bill 2015, clause 61A, p. 53.

[31]      Medical Research Future Fund Bill 2015, clause 62, pp 53–54.

[32]      Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 54.

[33]      These Commonwealth Acts are: the COAG Reform Fund Act 2008; the DisabilityCare Australia Fund Act 2013; the Health Insurance Act 1973; the Future Fund Act 2006 and the Nation-building Funds Act 2008.

[34]      Explanatory Memorandum, Medical Research Future Fund (Consequential Amendments) Bill 2015, p. 4.

[35]      Explanatory Memorandum, Medical Research Future Fund (Consequential Amendments) Bill 2015, p. 4.

[36]      House of Representatives Votes and Proceedings, No. 127—22 June 2015, p. 1425.

[37]      Supplementary Explanatory Memorandum, Medical Research Future Fund Bill 2015 and Medical Research Future Fund (Consequential Amendments) Bill 2015, p. 2.

[38]      Supplementary Explanatory Memorandum, Medical Research Future Fund Bill 2015 and Medical Research Future Fund (Consequential Amendments) Bill 2015, p. 7.

[39]      Supplementary Explanatory Memorandum, Medical Research Future Fund Bill 2015 and Medical Research Future Fund (Consequential Amendments) Bill 2015, p. 4.

[40]      Australian Government, Budget Paper No. 2 2014-15, p. 115, http://budget.gov.au/2014-15/content/bp2/download/BP2_consolidated.pdf, (accessed 20 July 2015). 

[41]      Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 4.

[42]      Australian Government, Budget Paper No. 2 2014-15, p. 115, http://budget.gov.au/2014-15/content/bp2/download/BP2_consolidated.pdf, (accessed 20 July 2015). 

[43]      Senate Standing Committee for the Scrutiny of Bills, Alert Digest No. 6 of 2015, pp 34–35.

[44]      Parliamentary Joint Committee on Human Rights, Human Rights Scrutiny Report: Twenty-third report of the 44^th Parliament; 18 June 2015, p. 2.

[45]      See: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/Future_Fund/Public_Hearings.

Chapter 2 - Key Issues

[1]        Mr Mark Cormack, Deputy Secretary, Strategic Policy and Innovate Group, Department of Health, Proof Committee Hansard, p. 32.

[2]        See for example: Australian Medical Association, Submission 50, p. 1.

[3]        MRFF AG, Submission 10, p. 3.

[4]        Professor Sharma Arun, Chair, Deputy Vice-Chancellor's Research Committee, Universities Australia, Proof Committee Hansard, p. 32.

[5]        House of Representatives Votes and Proceedings, No. 127—22 June 2015, p. 1425.

[6]        Supplementary Explanatory Memorandum, p. 10.

[7]        See for example: Cancer Voices Australia, Submission 1, p. 2; Deakin University, Submission 2, p. 2; Philanthropy Australia, Submission 6, p. 3; MRFF AG, Submission 10, p. 4; Research Australia, Submission 11, p. 2; Federation University Australia, Submission 15, p. 2; Multiple Sclerosis Research Australia, Submission 19, p. 2; University of Sydney, Submission 31, p. 2; Orygen, Submission 34, pp 2–3; Alzheimer's Australia, Submission 28, pp 2–3; University of Western Sydney, Submission 40, pp 2–3 and Australian Council of Trade Unions, Submission 45, p. 4.

[8]        Australian Academy of Science, Submission 4, pp 2–3.

[9]        Council of Academic Public Health Institutions Australia, Submission 36, p. 2.

[10]      Professor John Zalcberg OAM, Australian Clinical Trials, Proof Committee Hansard, pp 9–11.

[11]      See: ACTU, Submission 45, p. 4 and Supplementary Explanatory Memorandum, Medical Research Future Fund (Consequential Amendments) Bill 2015, p. 2.

[12]      See: Univeristy of Notre Dame, Submission 38, p. 3; Group of Eight, Submission 13, p. 2 and Professor Alan Pettigrew, Submission 18, p. 2.  

[13]      Mr Michael Wilson, CEO, JDRF Australia, Proof Committee Hansard, p. 2.

[14]      Mr Mark Cormack, Department of Health, Proof Committee Hansard, p. 53.

[15]      University of Tasmania, Submission 42, p. [2].

[16]      Orygen, Submission 34, p. [3].

[17]      Professor Steve Webb, Australian Clinical Trials Alliance, Proof Committee Hansard, p. 12.

[18]      Mr Mark Cormack, Department of Health, Proof Committee Hansard, p. 54.

[19]      Medical Research Future Fund Bill 2015, part 2A division 4 section 32G, p. 32.

[20]      Supplementary Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 2.

[21]      Whole of government submission, Submission 27, pp 7–8; Supplementary Explanatory Memorandum, p. 3.

[22]      Australian Academy of Science, Submission 4, p. 4.

[23]      Children's Cancer Institute, Submission 17, p. 1.

[24]      Mr Michael Wilson, CEO, Juvenile Diabetes Research Foundation Australia, Proof Committee Hansard, p. 4.

[25]      Professor John Zalcberg OAM, Australian Clinical Trials Alliance, Proof Committee Hansard, p. 12.

[26]      University of Sydney, Submission 31, p. 2.

[27]      See: Deakin University, Submission 2, p. 2; QIMR Berghofer Medical Research Institute, Submission 16, p. 1 and University of NSW, Submission 14, p. 2.

[28]      Dr Phoebe Phillips, Australian Society for Medical Research, Proof Committee Hansard, p. 19.

[29]      Explanatory Memorandum, p. 2.

[30]      Mr Michael Wilson, Juvenile Diabetes Research Foundation Australia, Proof Committee Hansard, p. 12.

[31]      Mr Ian Smith, Medical Research Future Fund Action Group, Proof Committee Hansard, p. 45. The Strategic Review of Health and Medical Research (McKeon Review) was established by the Australian Government in late 2011. This review reported to the Government in February 2013 and recommended a 10 year strategic health and medical research plan for the nation.

[32]      Professor Douglas Hilton, Medical Research Future Fund Action Group, Proof Committee Hansard, p. 52.

[33]      Australian Health Economics Society, Submission 5, p. 2; Innovative Research Universities, Submission 29, p. 2.

[34]      Medical Research Future Fund Bill 2015, section 5, p. 6.

[35]      Group of Eight Australia, Submission 13, p. [3].

[36]      Group of Eight Australia, Submission 13, p. [3].

[37]      Group of Eight Australia, Submission 13, p. [3]. See also: The University of Melbourne, Submission 26, pp 3–4.

[38]      University of New South Wales, Submission 14, p. 1.

[39]      Mr Nathan Smyth, First Assistant Secretary, Governance and Public Management, Department of Finance, Proof Committee Hansard, p. 59.

[40]      Medical Research Future Fund Bill 2015, section 5, p. 6.

[41]      MRFF AG, Submission 10, p. 3.

[42]      MRFF AG, Submission 10, p. 3. This alternative definition is supported by Research Australia, Submission 11, p. [1] and Multiple Sclerosis Research Australia, Submission 19, p. [2].

[43]      Australian Academy of Technological Sciences and Engineering, Submission 8, p. 2; University of Notre Dame, Submission 38, p. 2.

[44]      Mr Mark Cormack, Deputy Secretary, Strategic Policy and Innovation Group, Department of Health, Proof Committee Hansard, p. 53.

[45]      Mr Mark Cormack, Deputy Secretary, Strategic Policy and Innovation Group, Department of Health, Proof Committee Hansard, p. 54.

[46]      Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 4.

[47]      Mr Michael Wilson, Chief Operating Officer and Managing Director, Juvenile Diabetes Research Foundation Australia, Proof Committee Hansard, p. 1.

[48]      University of New South Wales, Submission 14, p. 2.

[49]      Deakin University, Submission 2; p. 1; Bionics Institute, Submission 3, p. 1; Submission 8, p. 2; Medicines Australia, Submission 9, p. 4; MRFF AG, Submission 10, p. 6; Knowledge Translation, Submission 12, pp 1–3; Biotech and Related Industries Leadership Group, Submission 20, pp 1–4; La Trobe University, Submission 30, p. 1; Universities Australia, Submission 32, pp 3–4; CSL, Submission 35, pp 20–23; University of Western Sydney, Submission 40, p. 2; The University of Wollongong, Submission 41, p. 3.

[50]      Deakin University, Submission 2, p. 1. See also: Universities Australia, Submission 32, p. 3. This submission states that 'research translation is essential and should be guided by national health priorities, noting that translation of research into clinical practice and preventative health strategies in Australia lags well behind research discoveries'.

[51]      Mr Mark Cormack, Deputy Secretary, Strategic Policy and Innovation Group, Department of Health, Proof Committee Hansard, p. 56.

[52]      Professor Anne Kelso, Chief Executive Officer, National Health and Medical Research Council, Proof Committee Hansard, pp 55–56.

[53]      Cancer Voices Australia, Submission 1, p. 2; Deakin University, Submission 2, p. 2; Australian Health Economics Society, Submission 5, p. 4; MRFF AG, Submission 10, pp 4–5; Federation University Australia, Submission 15, p. 3; University of Melbourne, Submission 26, pp. 2–3; Innovative Research Universities, Submission 29, p. 2; Orygen—The National Centre of Excellence in Youth Mental Health, Submission 34, p. 3.

[54]      Deakin University, Submission 2, p. 2; Australian Health Economics Society, Submission 5, p. 3; Australia Melanoma Consumer Alliance, Submission 23, p. 1; La Trobe University, Submission 30, p. 1.

[55]      Australian Academy of Science, Submission 4, p. 4.

[56]      Mr Mark Cormack, Deputy Secretary, Strategic Policy and Innovation Group, Department of Health, Proof Committee Hansard, p. 56.

[57]      Proof Committee Hansard, pp 40-41.

[58]      Proof Committee Hansard, p. 40.

[59]      Explanatory Memorandum, Medical Research Future Fund Bill 2015, p. 2. See also: Mr Mark Cormack, Deputy Secretary, Strategic Policy and Innovation Group, Department of Health, Proof Committee Hansard, p. 56.

Supplementary Report from the Australian Labor Party

[1] http://www.mckeonreview.org.au/downloads/Strategic_Review_of_Health_and_Medical_Research_Feb_2013-Final_Report.pdf p. 2

[2]        http://budget.gov.au/2014-15/content/glossy/health/download/Health.pdf p.5

[3]        Proof Committee Hansard, p. 55.

[4]        Dr Phoebe Phillips, President, Australian Society for Medical Research, Proof Committee Hansard, p. 19.

[5]        Answers to written questions on notice, received 5 August 2015, p. [1]

[6]        Submission 32, p. [1]

[7]        Submission 13, p. [2]

[8]        Proof Committee Hansard, p. 10.

[9]        Proof Committee Hansard, p. 20.

[10]      Proof Committee Hansard, p. 27.